UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Therapeutic advances in neurological disorders, 2021-01, Vol.14, p.17562864211012835-17562864211012835

2021

Volltextzugriff (PDF)

Deciphering the shift from benign to active relapsing-remitting multiple sclerosis: Insights into T regulatory cell dysfunction and apoptosis regulation

Neurobiology of disease, 2024-05, Vol.194, p.106475-106475, Article 106475

2024

Volltextzugriff (PDF)

Faster progression to multiple sclerosis disability is linked to neuronal pathways associated with neurodegeneration: An ethnicity study

PloS one, 2023-02, Vol.18 (2), p.e0280515-e0280515

2023

Volltextzugriff (PDF)

SARS‐CoV‐2 memory B and T cell profiles in mild COVID‐19 convalescent patients

International journal of infectious diseases, 2022-02, Vol.115, p.208-214

2022

Volltextzugriff (PDF)

Normalization of Large-Scale Transcriptome Data Using Heuristic Methods

Bioinformatics and biology insights, 2023-01, Vol.17, p.11779322231160397-11779322231160397

2023

Volltextzugriff (PDF)

RAM-589.555 favors neuroprotective and anti-inflammatory profile of CNS-resident glial cells in acute relapse EAE affected mice

Journal of neuroinflammation, 2020-10, Vol.17 (1), p.1-313, Article 313

2020

Volltextzugriff (PDF)

No immediate change in systemic cytokines following an eccentric muscle training session in people with multiple sclerosis

Therapeutic advances in neurological disorders, 2024-01, Vol.17, p.17562864241266113

2024

Volltextzugriff (PDF)

Microarray analysis identifies altered regulation of nuclear receptor family members in the pre-disease state of multiple sclerosis

Neurobiology of disease, 2010-05, Vol.38 (2), p.201-209

2010

Volltextzugriff (PDF)

Generation of vascular chimerism within donor organs

Scientific reports, 2021-06, Vol.11 (1), p.13437-13437, Article 13437

2021

Volltextzugriff (PDF)

Kidney Transplantation during the SARS-CoV-2 Pandemic in Israel: Experience from a Large-Volume Center

Transplantology (Basel, Switzerland), 2021-12, Vol.2 (4), p.433-440

2021

Volltextzugriff (PDF)

Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Therapeutic advances in neurological disorders, 2021, Vol.14, p.17562864211020082-17562864211020082

2021

Volltextzugriff (PDF)

The role of the vasculature niche on insulin-producing cells generated by transdifferentiation of adult human liver cells

Stem cell research & therapy, 2019-02, Vol.10 (1), p.53-53, Article 53

2019

Volltextzugriff (PDF)

Resolving bulimia nervosa using an innovative neural therapy approach: two case reports

Clinical case reports, 2018-02, Vol.6 (2), p.278-282

2018

Volltextzugriff (PDF)

Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells

BMC medical genomics, 2009-07, Vol.2 (1), p.46-46, Article 46

2009

Volltextzugriff (PDF)

Monocyte Derived Myeloid Suppressor Cell Subsets in the Central Nervous System Infiltrating Cells are Distinct from these in Peripheral Blood of Mice with Experimental Autoimmune Encephalomyelitis (4569)

Neurology, 2021-04, Vol.96 (15_supplement)

2021

Volltextzugriff (PDF)

SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects

Clinical microbiology and infection, 2021-09, Vol.27 (9), p.1349.e1-1349.e6

2021

Volltextzugriff (PDF)

Diversity in NIME Research Practices

Leonardo (Oxford), 2016-02, Vol.49 (1), p.80-81

Gurevich, Michael

2016

Volltextzugriff (PDF)

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

Multiple sclerosis, 2021-05, Vol.27 (6), p.864-870

2021

Volltextzugriff (PDF)

Molecular profiling of glatiramer acetate early treatment effects in multiple sclerosis

Disease markers, 2009-01, Vol.27 (2), p.63-73

2009

Volltextzugriff (PDF)

Heuristic normalization procedure for batch effect correction

Soft computing (Berlin, Germany), 2023-06, Vol.27 (12), p.7813-7829

2023

Volltextzugriff (PDF)

COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose

Journal of the neurological sciences, 2022-03, Vol.434, p.120155-120155, Article 120155

2022

Volltextzugriff (PDF)

Interacting with Cage: Realising classic electronic works with contemporary technologies

Organised sound : an international journal of music technology, 2015-12, Vol.20 (3), p.290-299

Gurevich, Michael

2015

Volltextzugriff (PDF)

Prickle1 as positive regulator of oligodendrocyte differentiation

Neuroscience, 2017-11, Vol.364, p.107-121

2017

Volltextzugriff (PDF)

Humoral SARS-COV-2 IgG decay within 6 months in COVID-19 healthy vaccinees: The need for a booster vaccine dose?

European journal of internal medicine, 2021-12, Vol.94, p.105-107

2021

Volltextzugriff (PDF)

Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod

Journal of neurology, 2022-05, Vol.269 (5), p.2286-2292

2022

Volltextzugriff (PDF)

1 – 25 von 208

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(174)
Mit Volltextzugriff
(160)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(206)
Hebräisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Deciphering the shift from benign to active relapsing-remitting multiple sclerosis: Insights into T regulatory cell dysfunction and apoptosis regulation

Faster progression to multiple sclerosis disability is linked to neuronal pathways associated with neurodegeneration: An ethnicity study

SARS‐CoV‐2 memory B and T cell profiles in mild COVID‐19 convalescent patients

Normalization of Large-Scale Transcriptome Data Using Heuristic Methods

RAM-589.555 favors neuroprotective and anti-inflammatory profile of CNS-resident glial cells in acute relapse EAE affected mice

No immediate change in systemic cytokines following an eccentric muscle training session in people with multiple sclerosis

Microarray analysis identifies altered regulation of nuclear receptor family members in the pre-disease state of multiple sclerosis

Generation of vascular chimerism within donor organs

Kidney Transplantation during the SARS-CoV-2 Pandemic in Israel: Experience from a Large-Volume Center

Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

The role of the vasculature niche on insulin-producing cells generated by transdifferentiation of adult human liver cells

Resolving bulimia nervosa using an innovative neural therapy approach: two case reports

Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells

Monocyte Derived Myeloid Suppressor Cell Subsets in the Central Nervous System Infiltrating Cells are Distinct from these in Peripheral Blood of Mice with Experimental Autoimmune Encephalomyelitis (4569)

SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects

Diversity in NIME Research Practices

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

Molecular profiling of glatiramer acetate early treatment effects in multiple sclerosis

Heuristic normalization procedure for batch effect correction

COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose

Interacting with Cage: Realising classic electronic works with contemporary technologies

Prickle1 as positive regulator of oligodendrocyte differentiation

Humoral SARS-COV-2 IgG decay within 6 months in COVID-19 healthy vaccinees: The need for a booster vaccine dose?

Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod

Aktive Filter

Suchergebnisse filtern